These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4006737)

  • 1. Phenytoin clearance by continuous ambulatory peritoneal dialysis.
    Hays DP; Primack WA; Abroms IF
    Drug Intell Clin Pharm; 1985 Jun; 19(6):429-31. PubMed ID: 4006737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of phenytoin in continuous ambulatory peritoneal dialysis. 2 cases and brief review of the literature].
    Hess B; Keusch G; Flückiger J; Binswanger U
    Schweiz Med Wochenschr; 1984 Jan; 114(1):16-9. PubMed ID: 6695161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of continuous ambulatory peritoneal dialysis on serum alpha 1-acid glycoprotein concentration and drug binding.
    Belpaire FM; Van de Velde EJ; Fraeyman NH; Bogaert MG; Lameire N
    Eur J Clin Pharmacol; 1988; 35(4):339-43. PubMed ID: 3197741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications.
    Hodler JE; Galeazzi RL; Frey B; Rudhardt M; Seiler AJ
    Eur J Clin Pharmacol; 1984; 26(5):609-12. PubMed ID: 6468477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Chin TW; Pancorbo S; Comty C
    Clin Exp Dial Apheresis; 1981; 5(4):391-7. PubMed ID: 7341025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic renal replacement therapy in children: which index is best for adequacy?
    Verrina E; Brendolan A; Gusmano R; Ronco C
    Kidney Int; 1998 Nov; 54(5):1690-6. PubMed ID: 9844146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Salahudeen AK; Wilkinson R; McAinsh J; Bateman DN
    Br J Clin Pharmacol; 1984 Sep; 18(3):457-60. PubMed ID: 6487486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of foscarnet during peritoneal dialysis.
    Alexander AC; Akers A; Matzke GR; Aweeka FT; Fraley DS
    Ann Pharmacother; 1996 Oct; 30(10):1106-9. PubMed ID: 8893116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Warady BA; Campoy SF; Gross SP; Sedman AB; Lum GM
    J Pediatr; 1984 Nov; 105(5):726-30. PubMed ID: 6502302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous ambulatory and continuous cycling peritoneal dialysis in children. A report of the Southwest Pediatric Nephrology Study Group.
    Kidney Int; 1985 Mar; 27(3):558-64. PubMed ID: 3999544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal kinetics in children undergoing continuous ambulatory/cycling peritoneal dialysis.
    von Lilien T; Salusky IB; Little RJ; Alliapolous JC; Leichter HE; Hall TL; Fine RN
    Am J Kidney Dis; 1987 Dec; 10(6):431-8. PubMed ID: 3120579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis rates and common microorganisms in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
    Akman S; Bakkaloglu SA; Ekim M; Sever L; Noyan A; Aksu N
    Pediatr Int; 2009 Apr; 51(2):246-9. PubMed ID: 19405925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 25-hydroxyvitamin D and vitamin D binding protein losses in thirteen children on continuous ambulatory peritoneal dialysis.
    Guillot M; Garabedian M; Lavocat C; Guillozo H; Gagnadoux MF; Balsan S; Broyer M
    Int J Pediatr Nephrol; 1983 Jun; 4(2):99-102. PubMed ID: 6688610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Kogan FJ; Sampliner RE; Mayersohn M; Kazama RM; Perrier D; Jones W; Michael UF
    J Clin Pharmacol; 1983; 23(5-6):252-6. PubMed ID: 6875024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis.
    Howard RL; Millspaugh J; Teitelbaum I
    Am J Kidney Dis; 1990 Nov; 16(5):469-72. PubMed ID: 2239939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of peritoneal dialysis method on residual renal function in children.
    Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.
    de Fijter CW; Verbrugh HA; Oe LP; Peters ED; van der Meulen J; Donker AJ; Verhoef J
    Kidney Int; 1992 Oct; 42(4):947-50. PubMed ID: 1453585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.